Calcium channel blockers
description, class of drug
Classes
dihydropyridines: nifedipine, amliodipine
non-dihydropyridines: verapamil, diltiazem
type here
good to combine with ACE/ARB
and beta blockers
Uses
- stable angina
- in ACS, generally only used acutely for ongoing ischemia when beta-blockers are contraindicated
Mechanism
- blocks Ca2+ influx into VSMCs and cardiomyocytes, leading to vasodilation and decreased contractility
- causes coronary/peripheral vasodilation, reducing contractility and MVO2
direct effect of reducing contractility may be counteracted by reduction in afterload and activation of
Members
- verapamil: cardiomyocyte and VSMC
- diltiazem: similar to verapamil
- dihydropyridines (ie nifedipine): VSMC
Dose and Half Life
Adverse Drug Reactions
short term
- avoid short acting dihydropyridines, ie nifedipine, due to its drop in BP
- non-dihydropyridines (verapamil and diltizaem) are negatively chronotropic and should generally be avoided in patients with poor LV function or HF
can cause headaches, flushing, dizziness
peripheral edema
constipation (verapamil)
bradycardia/heart block (verapamil, diltiaezm)
worsening heart failure
long term
Counter-Indications and Drug Interactions
Metabolism and Excretion
Dependency